Effect of Anticholinergic Medications on the Risk of Dementia: A Systematic Review and Meta-analysis Protocol
Open Access
- 1 January 2025
- journal article
- review article
- Published by Negah Scientific Publisher in Basic and Clinical Neuroscience Journal
- Vol. 16 (1) , 55-64
Abstract
Introduction: The most frequent dementia is senile dementia or Alzheimer disease. Meanwhile, anticholinergic drugs can potentially modify the risk factors. As different studies have achieved dissimilar results and the clinical findings of these interventions have not been conclusive, the objective of this research will be to evaluate the effect of ...Keywords
All Related Versions
This publication has 22 references indexed in Scilit:
- Effect of medications with anti-cholinergic properties on cognitive function, delirium, physical function and mortality: a systematic reviewAge and Ageing, 2014
- Prevalence and Predictors of Anticholinergic Agents in Elderly Outpatients with DementiaThe American Journal of Geriatric Pharmacotherapy, 2011
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Anticholinergic Medication Use and Cognitive Impairment in the Older Population: The Medical Research Council Cognitive Function and Ageing StudyJournal of the American Geriatrics Society, 2011
- Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analysesEuropean Journal of Epidemiology, 2010
- Measuring inconsistency in meta-analysesBMJ, 2003
- Survival Following a Diagnosis of Alzheimer DiseaseArchives of Neurology, 2002
- Alzheimer DiseaseJAMA, 2002
- The canine as a model of human cognitive aging: Recent developmentsProgress in Neuro-Psychopharmacology and Biological Psychiatry, 2000
- Patterns of mortality from types of dementia in the United States, 1971 and 1973–1978Neurology, 1986